A PET study in healthy subjects of brain exposure of 11 C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancer.

MLA

Varrone, Andrea, et al. “A PET Study in Healthy Subjects of Brain Exposure of 11 C-Labelled Osimertinib - A Drug Intended for Treatment of Brain Metastases in Non-Small Cell Lung Cancer.” Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism, vol. 40, no. 4, Apr. 2020, pp. 799–807. EBSCOhost, https://doi.org/10.1177/0271678X19843776.

APA

Varrone, A., Varnäs, K., Jucaite, A., Cselényi, Z., Johnström, P., Schou, M., Vazquez-Romero, A., Moein, M. M., Halldin, C., Brown, A. P., Vishwanathan, K., & Farde, L. (2020). A PET study in healthy subjects of brain exposure of 11 C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancer. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 40(4), 799–807. https://doi.org/10.1177/0271678X19843776

Chicago

Varrone, Andrea, Katarina Varnäs, Aurelija Jucaite, Zsolt Cselényi, Peter Johnström, Magnus Schou, Ana Vazquez-Romero, et al. 2020. “A PET Study in Healthy Subjects of Brain Exposure of 11 C-Labelled Osimertinib - A Drug Intended for Treatment of Brain Metastases in Non-Small Cell Lung Cancer.” Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism 40 (4): 799–807. doi:10.1177/0271678X19843776.